Allstate stock price target raised to $235 from $230 at BMO Capital

Allstate (NYSE:ALL) reported a significant beat on Q2 2025 earnings, with EPS of $5.94 against an anticipated $3.32 and revenue of $16.6 billion, prompting BMO Capital to raise its price target to $235 while maintaining an Outperform rating. This strong performance, which also led KBW and Wells Fargo to increase their price targets, reflects Allstate's robust financial health and upward revisions to future earnings estimates. However, BMO Capital noted potential near-term downside risks to auto policy-in-force (PIF) growth and resurfacing headwinds from certain brands, indicating a nuanced outlook despite the strong quarter.

Analysis

Allstate (ALL) has demonstrated significant operational strength, delivering a second-quarter 2025 earnings per share of $5.94, which represents a 78.92% surprise over the $3.32 consensus estimate. This robust performance, complemented by revenue of $16.6 billion surpassing the $15.22 billion forecast, has prompted multiple analysts to upgrade their outlook. BMO Capital raised its price target to $235, citing the earnings beat and a lower expense ratio, and consequently revised its 2025 EPS estimate upward by 18%. Similarly, Keefe, Bruyette & Woods and Wells Fargo also increased their price targets to $246 and $202, respectively. Despite this broad bullish sentiment, reflected by 12 upward analyst revisions and a stock price near its 52-week high, there are notable headwinds. BMO Capital highlights a potential downside risk to auto policy-in-force (PIF) growth in the third quarter unless retention improves, forecasting a 70 basis point decline. This caution is amplified by resurfacing issues from the Esurance and Encompass brands, weaker near-term buybacks, and a slightly higher underlying loss ratio linked to tariffs. While the company's fundamentals appear solid with a P/E of 9.74 and a "GREAT" financial health score, these specific operational risks present a more nuanced picture than the headline earnings suggest.

Key Decisions for Investors

• Investors should recognize the strong earnings momentum and positive analyst consensus, but must closely monitor upcoming auto policy-in-force (PIF) figures for validation of sustained organic growth.
• While the stock trades near its 52-week high, consider the offsetting factors presented, such as weaker near-term buybacks and headwinds from the Esurance and Encompass brands, which may temper future performance.
• It may be prudent to assess the risk of near-term downside in PIF growth, as flagged by BMO's sub-consensus forecasts for Q3 and Q4 2025, before initiating or adding to a position.